F.57. Elevated Serum Interferon Alpha Activity in Juvenile Dermatomyositis: Associations with Disease Activity at Diagnosis and After 36 Months of Therapy
暂无分享,去创建一个
[1] T. Niewold,et al. The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus. , 2008, Arthritis and rheumatism.
[2] J. Harley,et al. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. , 2008, Arthritis and rheumatism.
[3] Yi-Wen Chen,et al. Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis , 2008, BMC Immunology.
[4] B. Feldman,et al. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood , 2008, The Lancet.
[5] B. Feldman,et al. Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset. , 2008, Rheumatology.
[6] M. Crow,et al. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies , 2008, Annals of the rheumatic diseases.
[7] J. Buyon,et al. Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus. , 2008, Arthritis and rheumatism.
[8] A. Paller,et al. Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. , 2008, Arthritis and rheumatism.
[9] S. Pillemer,et al. Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept. , 2007, Arthritis and rheumatism.
[10] S. Kong,et al. Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. , 2007, Arthritis and rheumatism.
[11] Sharon Adams,et al. Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians. , 2006, Arthritis and rheumatism.
[12] L. Pachman,et al. MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement. , 2006, Clinical immunology.
[13] A. Takaoka,et al. Interferon signalling network in innate defence , 2006, Cellular microbiology.
[14] M. Crow,et al. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. , 2006, Arthritis and rheumatism.
[15] M. Peterson,et al. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. , 2005, Arthritis and rheumatism.
[16] A. Dyer,et al. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. , 2005, Arthritis and rheumatism.
[17] L. Rönnblom,et al. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism. , 2005, Arthritis and rheumatism.
[18] R. Bode,et al. Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. , 2003, Arthritis and rheumatism.
[19] C. Berry,et al. Self epitopes shared between human skeletal myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis. , 2002, Arthritis and rheumatism.
[20] F. Lund-Johansen,et al. Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. , 2001, The American journal of pathology.
[21] R. Albertini,et al. Association among somatic HPRT mutant frequency, peripheral blood T-lymphocyte clonality, and serologic parameters of disease activity in children with juvenile onset dermatomyositis. , 1999, Clinical immunology.
[22] M. Christensen,et al. Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis. , 1995, Arthritis and rheumatism.
[23] S. Albani,et al. Recurrent juvenile dermatomyositis and cutaneous necrotizing arteritis with molecular mimicry between streptococcal type 5 M protein and human skeletal myosin. , 1992, The Journal of pediatrics.
[24] C. Ober,et al. Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with HLA-DQA1 *0501. , 1991, Human immunology.
[25] V. Dubowitz,et al. DERMATOMYOSITIS, POLYMYOSITIS, AND COXSACKIE-B-VIRUS INFECTION , 1987, The Lancet.
[26] J. Friedman,et al. Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis. , 1986, Arthritis and rheumatism.
[27] H. Moutsopoulos,et al. Detection of anti-interferon antibodies in systemic lupus erythematosus. , 1983, Clinical and experimental rheumatology.
[28] T. Schnitzer,et al. Serum interferon levels in patients with systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[29] A. Notkins,et al. Immune interferon in the circulation of patients with autoimmune disease. , 1979, The New England journal of medicine.
[30] J. Brody,et al. Antibody levels to parainfluenza, rubella, measles, and influenza A virus in children with polymyositis. , 1975, Arthritis and rheumatism.
[31] J. Harley,et al. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. , 2007, Genes and immunity.
[32] P. Gregersen,et al. An Interferon Signature in the Peripheral Blood of Dermatomyositis Patients is Associated with Disease Activity , 2007, Molecular medicine.
[33] V. Pascual,et al. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[34] L. Pachman,et al. TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. , 2000, Arthritis and rheumatism.
[35] R. Zawatzky,et al. Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFN-alpha and IFN-beta. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.